Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRCP | P42785 | 1/20 | 0.44 |
| ▸ | OPRM1 | P35372 | 7/20 | 0.43 |
| ▸ | OPRK1 | P41145 | 7/20 | 0.43 |
| ▸ | ACE | P12821 | 2/20 | 0.43 |
| ▸ | APLNR | P35414 | 3/20 | 0.41 |
| ▸ | DPP4 | P27487 | 1/20 | 0.41 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.41 |
| ▸ | TLR2 | O60603 | 2/20 | 0.41 |
| ▸ | NTMT1 | Q9BV86 | 1/20 | 0.40 |
| ▸ | STAT6 | P42226 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31437210 | 0.93 | ACE (0.44) | PRCPOPRM1OPRK1ACESTAT6 | |
| SCHEMBL31437205 | 0.93 | OPRM1 (0.45) | OPRM1OPRK1APLNR | |
| SCHEMBL31437183 | 0.93 | PRCP (0.43) | PRCPOPRM1OPRK1ACEAPLNR | |
| SCHEMBL31437182 | 0.92 | F2 (0.41) | PRCPOPRM1OPRK1ACEAPLNR | |
| SCHEMBL31437197 | 0.90 | PRCP (0.47) | PRCPOPRM1OPRK1ACEDPP4 | |
| SCHEMBL31437193 | 0.89 | PRCP (0.51) | PRCPACEDPP4DPP8TLR2 | |
| SCHEMBL31467758 | 0.89 | PRCP (0.46) | PRCPOPRM1OPRK1ACE | |
| SCHEMBL31467771 | 0.87 | PRCP (0.43) | PRCPOPRM1OPRK1ACE | |
| SCHEMBL31467760 | 0.84 | PRCP (0.45) | PRCPOPRM1OPRK1ACE | |
| SCHEMBL9815799 | 0.83 | OPRM1 (0.49) | PRCPOPRM1OPRK1STAT6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025037992-A1 | NEW PEPTIDES AND USE THEREOF | MAJEWSKI FILIP (PL) | 2025-02-20 | — | — | WO | disclosed |
| WO-2025037993-A1 | DOSAGE FORM FOR PEPTIDE AGENTS | MAJEWSKI FILIP (PL) | 2025-02-20 | — | — | WO | disclosed |